A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This essential tumor inhibitor protein is frequently disabled in various kinds of tumors, causing https://ez-bookmarking.com/story21890299/mini-antibodies-revive-tumor-suppressor-p53-new-new-hope-for-malignant-therapy